We
typically think a toxic agent has to be inhaled to cause lung disease;
think of asbestos or silica, for example. But two new studies by the Arsenic
Health Effects Research Program (AHERP) at the University of California
Berkeley challenge this thinking. The studies’ findings show that
arsenic, a known skin, bladder, and lung carcinogen, can also cause non-cancerous
lung disease when swallowed.
In
two separate studies to be published this fall, the arsenic research group
demonstrates that drinking tube-well water with high concentrations of
arsenic was associated with compromised pulmonary function in men and
high rates of bronchiectasis – distortion and dilation of the bronchi,
which can lead to chronic infections and obstructive lung disease.
The studies were designed by Allan H. Smith, director
of AHERP, in collaboration with D. N. Guha Mazumder of the Institute of
Post Graduate Medical Education and Research in Kolkata, India. The studies
recruited subjects from a rural population in West Bengal, India, which,
along with Bangladesh, is home to millions of people exposed to arsenic
through drinking water. When ingested over a long period of time, arsenic
causes unique skin lesions, giving the researchers a convenient way to
identify people who have been exposed to high amounts of the element.
The first publication, whose lead author, Ondine von Ehrenstein,
is an environmental epidemiologist at UCB who directs AHERP’s India
studies, compared lung function in people with arsenic-caused skin lesions
to a matched group with no lesions. Men with lesions and high arsenic
exposure had greatly reduced forced expiratory volume in 1 second tests
(FEV1) and forced vital capacity (FVC)—measures of the volume of
air a person can force out following a deep breath, after one second and
in total. This study was funded by the U.S. Environmental Protection Agency
and by the National Institute of Environmental Health Sciences (NIEHS)
Superfund Basic Research Program at UCB.
In a related study on bronchiectasis, people with skin lesions who had
been exposed to drinking water containing high concentrations of arsenic
were compared to individuals without skin lesions who had low exposures.
The prevalence of bronchiectasis, measured by high resolution computed
tomography, was ten times higher in people with skin lesions than in the
control group. Craig Steinmaus of AHERP, an assistant
professor in occupational and environmental medicine at UCSF, took the
lead in analyzing the data and writing up the study, which was funded
by the NIEHS Superfund Basic Research Program.
Both studies found that ingested arsenic appears to take a greater toll
on the lungs of men than women. Men in the study populations smoked far
more than women, but the researchers found that gender differences in
arsenic-induced lung disease remained even after ruling out smoking as
a complicating factor. Why men would be more susceptible than women remains
a mystery.
The installation of tube-wells in India and Bangladesh was undertaken
by international aid agencies mainly in the 1970s and 1980s to improve
water supplies and to cut down on high rates of diarrheal disease caused
by bacterial contamination of drinking water. The wells did help reduce
the transmission of gastrointestinal diseases resulting in significant
reductions in infant mortality. But because the water in many of them
has such high concentrations of arsenic, a whole new set of health risks
has been introduced.
Von Ehrenstein and the AHERP team are currently completing another study
in West Bengal funded by UNICEF, looking at health effects in women and
children who were drinking water with high arsenic concentration in comparison
to a group of women and children with low exposure. Among the women she
is particularly looking at the impact of exposure during pregnancy. The
study is examining reproductive outcomes, like stillbirths and cognitive
effects in young children.
Steinmaus, who mainly works on arsenic studies in California and Latin
America, is also now looking at the effects of arsenic on children, in
Antofagasta, Chile. The parched city drew arsenic-laden drinking water
from rivers originating as springs in the Andes mountains from 1958 to
1971, when exposure was reduced through the installation of the first
major arsenic removal plant in the world.
Preliminary data from Antofagasta suggest that those who were in utero
or young children there in the 1960s have startlingly higher rates of
cancer than those in the rest of Chile, or even those who were young adults
or older when exposed to the water in Antofagasta. Steinmaus is hoping
his future research will elucidate the relationship between age at exposure
and risk of disease later in life.

